|
Market Closed -
Euronext Paris
18:55:00 21/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.308 EUR | +0.77% |
|
+2.99% | -40.27% |
| 10-12 | Crossject: No market launch of Zepizure before H127 at best | AL |
| 09-25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CROSSJECT | Drug Delivery Systems | +0.77% | +2.99% | -40.27% | -46.50% | -58.48% | 79.39M |  | | |
- Stock Market
- Stocks
- ALCJ Stock
- Charts Crossject
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
